The IGF-I generation test revisited: how does IGF-I and IGFBP-3 increase predict responsiveness to therapy in children under rhGH treatment?

被引:0
|
作者
Weigel, Johannes [1 ]
Christof, Meigen [2 ]
Eberhardt, Keller [2 ]
Juergen, Kratzsch [3 ]
Ruth, Gausche [2 ]
Wieland, Kiess [1 ]
Roland, Pfaeffle [1 ]
机构
[1] Univ Leipzig, Univ Childrens Hosp, Leipzig, Saxonia, Germany
[2] Univ Leipzig, CrescNet, Leipzig, Saxonia, Germany
[3] Univ Leipzig, Dept Clin Chem, Leipzig, Saxonia, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:380 / 381
页数:2
相关论文
共 50 条
  • [21] PLASMA GHRELIN, SERUM IGF-I AND IGFBP-3 LEVELS IN OBESE CHILDREN
    Cinaz, Peyami
    Yesilkaya, Ediz
    Kaya, Aysenur
    JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2009, 72 (02): : 47 - 51
  • [22] Modulation of IGF-I therapy by IGFBP-3: Potential utility in wound healing
    Rosen, DM
    Adams, S
    Moore, JA
    Maack, CA
    Sommer, A
    GROWTH FACTORS AND WOUND HEALING: BASIC SCIENCE AND POTENTIAL CLINICAL APPLICATIONS, 1997, : 281 - 290
  • [23] IGF-I and IGFBP-3 as markers for monitoring GH therapy in GH-deficient children
    Boettcher, Claudia
    Shavrikova, Elena P.
    Crowe, Brenda J.
    Wudy, Stefan A.
    Blum, Werner F.
    HORMONE RESEARCH, 2008, 70 : 99 - 99
  • [24] Significant increase of IGF-I concentration and of IGF-I/IGFBP-3 molar ratio in generation test predicts the good response to growth hormone (GH) therapy in children with short stature and normal results of GH stimulating tests
    Smyczynska, Joanna
    Hilczer, Maciej
    Stawerska, Renata
    Lewinski, Andrzej
    NEUROENDOCRINOLOGY LETTERS, 2013, 34 (03) : 222 - 228
  • [25] Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 Molar Ratio and Risk of Pancreatic Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    Douglas, Jason B.
    Silverman, Debra T.
    Pollak, Michael N.
    Tao, Yuzhen
    Soliman, Amr S.
    Stolzenberg-Solomon, Rachael Z.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (09) : 2298 - 2306
  • [26] Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    Douglas, Jason B.
    Silverman, Debra T.
    Pollak, Michael N.
    Tao, Yuzhen
    Soliman, Amr S.
    Stolzenberg-Solomon, Rachael Z.
    CANCER RESEARCH, 2010, 70
  • [27] IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome
    Sierra-Johnson, Justo
    Romero-Corral, Abel
    Somers, Virend K.
    Lopez-Jimenez, Francisco
    Malarstig, Anders
    Brismar, Kerstin
    Hamsten, Anders
    Fisher, Rachel M.
    Hellenius, Mai-Lis
    CLINICAL SCIENCE, 2009, 116 (5-6) : 507 - 512
  • [28] Increased IGF-I:IGFBP-3 ratio in patients with hepatocellular carcinoma
    Mattera, D
    Capuano, G
    Colao, A
    Pivonello, R
    Manguso, F
    Puzziello, A
    D'Agostino, L
    CLINICAL ENDOCRINOLOGY, 2003, 59 (06) : 699 - 706
  • [29] Effects of aging and caloric restriction on IGF-I, IGF-I receptor, IGFBP-3 and IGFBP-4 gene expression in the rat stomach and colon
    Hallberg, LM
    Ikeno, Y
    Englander, E
    Greeley, GH
    REGULATORY PEPTIDES, 2000, 89 (1-3) : 37 - 44
  • [30] IGF-I, IGFBP-3, AND BONE MASS IN ATHLETIC WOMEN AND CONTROLS
    SNOWHARTER, CM
    ROSEN, CJ
    ROBINSON, TL
    JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 : S247 - S247